OPCH vs. AMED, BTSG, CHE, ADUS, LNTH, OGN, BLCO, HALO, APLS, and BBIO
Should you be buying Option Care Health stock or one of its competitors? The main competitors of Option Care Health include Amedisys (AMED), BrightSpring Health Services (BTSG), Chemed (CHE), Addus HomeCare (ADUS), Lantheus (LNTH), Organon & Co. (OGN), Bausch + Lomb (BLCO), Halozyme Therapeutics (HALO), Apellis Pharmaceuticals (APLS), and BridgeBio Pharma (BBIO). These companies are all part of the "medical" sector.
Amedisys (NASDAQ:AMED) and Option Care Health (NASDAQ:OPCH) are both mid-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, dividends, analyst recommendations, risk, media sentiment, community ranking and valuation.
Amedisys has a beta of 0.84, indicating that its stock price is 16% less volatile than the S&P 500. Comparatively, Option Care Health has a beta of 1.26, indicating that its stock price is 26% more volatile than the S&P 500.
In the previous week, Amedisys had 1 more articles in the media than Option Care Health. MarketBeat recorded 6 mentions for Amedisys and 5 mentions for Option Care Health. Amedisys' average media sentiment score of 1.40 beat Option Care Health's score of 1.12 indicating that Option Care Health is being referred to more favorably in the news media.
94.4% of Amedisys shares are owned by institutional investors. Comparatively, 98.1% of Option Care Health shares are owned by institutional investors. 1.8% of Amedisys shares are owned by insiders. Comparatively, 0.6% of Option Care Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Amedisys currently has a consensus price target of $100.80, indicating a potential upside of 5.27%. Option Care Health has a consensus price target of $40.00, indicating a potential upside of 31.67%. Given Amedisys' stronger consensus rating and higher probable upside, analysts clearly believe Option Care Health is more favorable than Amedisys.
Amedisys received 449 more outperform votes than Option Care Health when rated by MarketBeat users. However, 58.97% of users gave Option Care Health an outperform vote while only 58.93% of users gave Amedisys an outperform vote.
Option Care Health has higher revenue and earnings than Amedisys. Amedisys is trading at a lower price-to-earnings ratio than Option Care Health, indicating that it is currently the more affordable of the two stocks.
Option Care Health has a net margin of 6.15% compared to Option Care Health's net margin of -0.91%. Amedisys' return on equity of 18.92% beat Option Care Health's return on equity.
Summary
Option Care Health beats Amedisys on 14 of the 18 factors compared between the two stocks.
Get Option Care Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for OPCH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding OPCH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Option Care Health Competitors List
Related Companies and Tools
